C4 Therapeutics, Inc. (CCCC)
4.11
+0.11
(+2.75%)
USD |
NASDAQ |
Aug 24, 16:00
4.07
-0.04
(-0.97%)
After-Hours: 20:00
C4 Therapeutics Total Assets (Quarterly) : 359.40M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 359.40M |
| March 31, 2026 | 328.86M |
| December 31, 2025 | 371.94M |
| September 30, 2025 | 265.49M |
| June 30, 2025 | 296.53M |
| March 31, 2025 | 319.52M |
| December 31, 2024 | 349.60M |
| September 30, 2024 | 376.06M |
| June 30, 2024 | 381.09M |
| March 31, 2024 | 398.37M |
| December 31, 2023 | 376.45M |
| September 30, 2023 | 333.01M |
| June 30, 2023 | 375.01M |
| March 31, 2023 | 396.04M |
| Date | Value |
|---|---|
| December 31, 2022 | 430.84M |
| September 30, 2022 | 461.44M |
| June 30, 2022 | 492.48M |
| March 31, 2022 | 515.48M |
| December 31, 2021 | 506.76M |
| September 30, 2021 | 507.91M |
| June 30, 2021 | 528.42M |
| March 31, 2021 | 374.01M |
| December 31, 2020 | 400.14M |
| September 30, 2020 | 229.13M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 118.26M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cartesian Therapeutics, Inc. | 318.63M |
| Beam Therapeutics, Inc. | 1.386B |
| Rallybio Corp. | 98.06M |
| Q32 Bio, Inc. | 115.87M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 112.14M |
| Shareholders Equity (Quarterly) | 247.26M |
| Debt to Equity Ratio | 0.2299 |
| Current Ratio | 5.449 |
| Net Debt Paydown Yield | 0.26% |